The SURMOUNT trial data at lowest doses The SURMOUNT-1 trial, published in the New England Journal of Medicine, tested tirzepatide at 5 mg, 10 mg, and 15 mg, but not below 5 mg
The drug can accelerate progress, but it does not replace the work.
If you use the time on the medication to reset your microvascular system, build muscle with ARX or other suitable resistance training, and optimize your nutrition, you are far more likely to maintain your results
Underpinned by early research on the role of the inflammatory response in IBS and the possible benefits of antioxidant therapy for IBD patients, the possibility of glutathione as an effective supplement for IBS is becoming increasingly prominent.* Although future research in humans and animals will confirm the value of glutathione for IBS and IBD, patients can already work with their practitioner to explore how glutathione supplementation can become part of their therapeutic strategy
As of 2026, an HDHP must carry a minimum deductible of $1,700 for self-only coverage or $3,400 for family coverage